MX9604309A - Aumento de la eficacia de drogas por deuteracion. - Google Patents

Aumento de la eficacia de drogas por deuteracion.

Info

Publication number
MX9604309A
MX9604309A MX9604309A MX9604309A MX9604309A MX 9604309 A MX9604309 A MX 9604309A MX 9604309 A MX9604309 A MX 9604309A MX 9604309 A MX9604309 A MX 9604309A MX 9604309 A MX9604309 A MX 9604309A
Authority
MX
Mexico
Prior art keywords
nifedipine
drugs
isotope
molecular
deuterated
Prior art date
Application number
MX9604309A
Other languages
English (en)
Other versions
MXPA96004309A (es
Inventor
Robert R Foster
Richard Lewanczuk
Gilles Caille
Original Assignee
Isotechnika Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isotechnika Inc filed Critical Isotechnika Inc
Publication of MX9604309A publication Critical patent/MX9604309A/es
Publication of MXPA96004309A publication Critical patent/MXPA96004309A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se

Abstract

La presente invencion se refiere a un procedimiento para aumentar la eficacia de productos farmacéuticos o drogas conocidas y a las drogas mejoradas así producidas , por el cambio de la forma isotopica de la estructura molecular de la droga conocida. Más particularmente, la presente invencion se refiere a la modificacion de la estructura molecular de drogas conocidas, que contienen uno o más átomos de hidrogeno, por la deuteracion de uno o más de estos átomos de hidrogeno en átomos de deuterio. La droga resultante se altera significantemente y tiene una actividad mejorada sobre la droga conocida. Más
MXPA/A/1996/004309A 1994-03-25 1996-09-25 Aumento de la eficacia de drogas por deuteracion MXPA96004309A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21789794A 1994-03-25 1994-03-25
US217897 1994-03-25
PCT/CA1995/000154 WO1995026325A2 (en) 1994-03-25 1995-03-27 Enhancement of the efficacy of drugs by deuteration

Publications (2)

Publication Number Publication Date
MX9604309A true MX9604309A (es) 1998-05-31
MXPA96004309A MXPA96004309A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
BR9507200A (pt) 1997-09-16
ES2293638T3 (es) 2008-03-16
WO1995026325A2 (en) 1995-10-05
KR100477070B1 (ko) 2006-04-21
DE69535592T2 (de) 2008-06-12
WO1995026325A3 (en) 1995-12-14
DE69535592D1 (de) 2007-10-25
CN1087725C (zh) 2002-07-17
KR20040068613A (ko) 2004-07-31
JP3696884B2 (ja) 2005-09-21
EP0751926A1 (en) 1997-01-08
CA2186371A1 (en) 1995-10-05
ATE372966T1 (de) 2007-09-15
JPH09510717A (ja) 1997-10-28
EP0751926B1 (en) 2007-09-12
AU707748B2 (en) 1999-07-22
CN1148843A (zh) 1997-04-30
US5846514A (en) 1998-12-08
AU1944195A (en) 1995-10-17

Similar Documents

Publication Publication Date Title
WO1995026325A3 (en) Enhancement of the efficacy of drugs by deuteration
WO1995026325B1 (en) Enhancement of the efficacy of drugs by deuteration
ATE314388T1 (de) Deuterierte und undeuterierte cyclosporin-analoga und ihre verwendung als immunmodulierende agentien
MY120279A (en) Use of a celecoxib composition for fast pain relief
NZ502358A (en) Hydrogel composition comprising a biologically active substance combined with a macromer
ATE220329T1 (de) Zusammensetzung enthaltend bradykinin zum selektiven offnen von anormalen gehirngewebes kapillaren
DE60210413D1 (de) Zusammensetzungen zur immunisierung sowie deren verwendung
NO178105C (no) Tramadol-N-oksydmateriale, enantiomerer og preparater derav
EP1362127A4 (en) SERPIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV INFECTION AND THE USE THEREOF
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
HK1018590A1 (en) Administration regimen of h+, k+-atpase inhibitors
FI973691A (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia
DK1051159T3 (da) Faste farmaceutiske præparater indeholdende miltefosin til oral administration ved behandling af leishmaniasis
MX9700245A (es) Nuevo compuesto quimico, su preparacion y su empleo como medicamento.
DE69628743D1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
EA200200502A1 (ru) Способ введения ингибитора фосфодиэстеразы 4
ITMI911038A0 (it) Processo per l'assorbimento di gas residui in particolare azoto, mediante una lega getter a base di bario non evaporato
BG104014A (en) High transparancy polymer composition
FI900175A0 (fi) Menetelmä valmistaa farmaseuttisesti arvokkaita fuusioituja bentsatsepiineja
MXPA02011592A (es) Composiciones de celulas dendriticas circulantes, humanas y metodos.
ES2150929T3 (es) Procedimiento para la obtencion de 3,7-dialquilxantinas a partir de 3-alquilxantinas.
WO2003044837A3 (en) Ion imlantation method and apparatus
IL150638A0 (en) Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
BG104839A (en) Chrystalline form of paroxetine
UA37666A (uk) Спосіб комлексної терапії простої шизофренії з суїцидальною поведінкою